SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-051856
Filing Date
2023-04-28
Accepted
2023-04-28 06:00:40
Documents
10
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm231888-2_def14a.htm DEF 14A 1376715
2 GRAPHIC lg_mersanatherapeu-4c.jpg GRAPHIC 56629
3 GRAPHIC bc_directors-4c.jpg GRAPHIC 196219
4 GRAPHIC ic_tick-bw.jpg GRAPHIC 1840
5 GRAPHIC ic_cross-bw.jpg GRAPHIC 1832
6 GRAPHIC eq_annual-bw.jpg GRAPHIC 39739
7 GRAPHIC bc_tsr-4c.jpg GRAPHIC 166001
8 GRAPHIC bc_netloss-4c.jpg GRAPHIC 116811
9 GRAPHIC px_proxypg1-bw.jpg GRAPHIC 736640
10 GRAPHIC px_proxypg2-bw.jpg GRAPHIC 566130
  Complete submission text file 0001104659-23-051856.txt   3660354
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38129 | Film No.: 23859808
SIC: 2834 Pharmaceutical Preparations